Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Lacosamide UCB, lacosamide, Date of authorisation: 26/08/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Lacosamide UCB, lacosamide, Date of authorisation: 26/08/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

Committee for Medicinal Products for Veterinary Use (CVMP): 13-15 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2024 to 15 February 2024

Committee for Medicinal Products for Veterinary Use (CVMP): 13-15 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2024 to 15 February 2024

Human medicines European public assessment report (EPAR): Exblifep, cefepime,enmetazobactam, Date of authorisation: 21/03/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Exblifep, cefepime,enmetazobactam, Date of authorisation: 21/03/2024, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness